Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gigantism refers to abnormally high linear growth due to excessive action of insulinlike growth factor I (IGF-I) while the epiphyseal growth plates are open during childhood. Acromegaly is the same disorder of IGF-I excess but occurs after the growth plate cartilage fuses in adulthood.
The global acromegaly and gigantism treatment market can be segmented into treatment, end users, and geographical expansion. On the basis of treatment, the market is divided into surgery, radiation therapy, and medication. The medication segment can be further divided into different drug types such as somatostatin analogs, GH receptor antagonists, dopamine agonists and others. The medication segment is expected to hold a significant market share during the forecast period due to factors such as effectiveness of drugs, noninvasive and lesser side effects than radiation therapies, and strong pipeline portfolio.
This report elaborates on the current development of the Acromegaly and Gigantism Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Ipsen
Novartis
By Type:
Dopamine Agonists
Somatostatin Analogs
Recombinant Human IGF-1
GH Receptor Antagonists
By Application:
Others
Clinics
Hospitals
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Acromegaly and Gigantism Drugs Market Overview 2018-2029
-
1.1 China Acromegaly and Gigantism Drugs Industry Development Overview
-
1.2 China Acromegaly and Gigantism Drugs Industry Development History
-
1.3 China Acromegaly and Gigantism Drugs Industry Market Size (2018-2029)
-
1.4 China Acromegaly and Gigantism Drugs Market Analysis by Type from Production Side
-
1.4.1 China Acromegaly and Gigantism Drugs Production Volume, Production Value and Growth Rate of Dopamine Agonists (2018-2029)
-
1.4.2 China Acromegaly and Gigantism Drugs Production Volume, Production Value and Growth Rate of Somatostatin Analogs (2018-2029)
-
1.4.3 China Acromegaly and Gigantism Drugs Production Volume, Production Value and Growth Rate of Recombinant Human IGF-1 (2018-2029)
-
1.4.4 China Acromegaly and Gigantism Drugs Production Volume, Production Value and Growth Rate of GH Receptor Antagonists (2018-2029)
-
1.5 China Acromegaly and Gigantism Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Acromegaly and Gigantism Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.2 China Acromegaly and Gigantism Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
1.5.3 China Acromegaly and Gigantism Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.6 China Acromegaly and Gigantism Drugs Market Analysis by Region
-
1.6.1 North China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Acromegaly and Gigantism Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Acromegaly and Gigantism Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Acromegaly and Gigantism Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Acromegaly and Gigantism Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Acromegaly and Gigantism Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Acromegaly and Gigantism Drugs Industry Development
Chapter 3 Acromegaly and Gigantism DrugsIndustry Chain Analysis
-
3.1 Acromegaly and Gigantism Drugs Industry Chain
-
3.2 Acromegaly and Gigantism Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Acromegaly and Gigantism Drugs Market
-
3.3 Acromegaly and Gigantism Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Acromegaly and Gigantism Drugs Market
Chapter 4 China Acromegaly and Gigantism Drugs Market, by Type
-
4.1 China Acromegaly and Gigantism Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Acromegaly and Gigantism Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Acromegaly and Gigantism Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Acromegaly and Gigantism Drugs Production Volume and Growth Rate of Dopamine Agonists
-
4.5.2 China Acromegaly and Gigantism Drugs Production Volume and Growth Rate of Somatostatin Analogs
-
4.5.3 China Acromegaly and Gigantism Drugs Production Volume and Growth Rate of Recombinant Human IGF-1
-
4.5.4 China Acromegaly and Gigantism Drugs Production Volume and Growth Rate of GH Receptor Antagonists
Chapter 5 China Acromegaly and Gigantism Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Acromegaly and Gigantism Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Acromegaly and Gigantism Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Acromegaly and Gigantism Drugs Market Size and Growth Rate of Others
-
5.5.2 China Acromegaly and Gigantism Drugs Market Size and Growth Rate of Clinics
-
5.5.3 China Acromegaly and Gigantism Drugs Market Size and Growth Rate of Hospitals
Chapter 6 China Acromegaly and Gigantism Drugs Market, by Region
-
6.1 China Acromegaly and Gigantism Drugs Production Volume and Production Value, by Region
-
6.2 China Acromegaly and Gigantism Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Acromegaly and Gigantism Drugs Market Analysis
-
7.1 North China Acromegaly and Gigantism Drugs Market, by Type
-
7.2 North China Acromegaly and Gigantism Drugs Market, by Application
Chapter 8 Central China Acromegaly and Gigantism Drugs Market Analysis
-
8.1 Central China Acromegaly and Gigantism Drugs Market, by Type
-
8.2 Central China Acromegaly and Gigantism Drugs Market, by Application
Chapter 9 South China Acromegaly and Gigantism Drugs Market Analysis
-
9.1 South China Acromegaly and Gigantism Drugs Market, by Type
-
9.2 South China Acromegaly and Gigantism Drugs Market, by Application
Chapter 10 East China Acromegaly and Gigantism Drugs Market Analysis
-
10.1 East China Acromegaly and Gigantism Drugs Market, by Type
-
10.2 East China Acromegaly and Gigantism Drugs Market, by Application
Chapter 11 Northeast China Acromegaly and Gigantism Drugs Market Analysis
-
11.1 Northeast China Acromegaly and Gigantism Drugs Market, by Type
-
11.2 Northeast China Acromegaly and Gigantism Drugs Market, by Application
Chapter 12 Southwest China Acromegaly and Gigantism Drugs Market Analysis
-
12.1 Southwest China Acromegaly and Gigantism Drugs Market, by Type
-
12.2 Southwest China Acromegaly and Gigantism Drugs Market, by Application
Chapter 13 Northwest China Acromegaly and Gigantism Drugs Market Analysis
-
13.1 Northwest China Acromegaly and Gigantism Drugs Market, by Type
-
13.2 Northwest China Acromegaly and Gigantism Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Ipsen
-
14.1.1 Ipsen Company Profile
-
14.1.2 Ipsen Acromegaly and Gigantism Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Novartis
-
14.2.1 Novartis Company Profile
-
14.2.2 Novartis Acromegaly and Gigantism Drugs Market Performance
-
14.2.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Acromegaly and Gigantism Drugs Industry Research Conclusions
-
15.2 Acromegaly and Gigantism Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Acromegaly and Gigantism Drugs Industry Market Size (2018-2029)
-
Figure China Acromegaly and Gigantism Drugs Production Volume, Production Value and Growth Rate of Dopamine Agonists (2018-2029)
-
Figure China Acromegaly and Gigantism Drugs Production Volume, Production Value and Growth Rate of Somatostatin Analogs (2018-2029)
-
Figure China Acromegaly and Gigantism Drugs Production Volume, Production Value and Growth Rate of Recombinant Human IGF-1 (2018-2029)
-
Figure China Acromegaly and Gigantism Drugs Production Volume, Production Value and Growth Rate of GH Receptor Antagonists (2018-2029)
-
Figure China Acromegaly and Gigantism Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Acromegaly and Gigantism Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
Figure China Acromegaly and Gigantism Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure North China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Acromegaly and Gigantism Drugs Market Size and Growth Rate from 2018-2029
-
Figure Acromegaly and Gigantism Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Acromegaly and Gigantism Drugs Market Share by Type in 2018
-
Figure China Acromegaly and Gigantism Drugs Market Share by Type in 2023
-
Figure China Acromegaly and Gigantism Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Production Volume and Growth Rate of Dopamine Agonists (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Production Volume and Growth Rate of Somatostatin Analogs (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Production Volume and Growth Rate of Recombinant Human IGF-1 (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Production Volume and Growth Rate of GH Receptor Antagonists (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Market Share by Application in 2018
-
Figure China Acromegaly and Gigantism Drugs Market Share by Application in 2023
-
Figure China Acromegaly and Gigantism Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Acromegaly and Gigantism Drugs Market Size and Growth Rate of Others (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Market Size and Growth Rate of Clinics (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Market Size and Growth Rate of Hospitals (2018-2023)
-
Table China Acromegaly and Gigantism Drugs Production Volume by Region (2018-2023)
-
Table China Acromegaly and Gigantism Drugs Production Volume Share by Region (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Production Volume Share by Region (2018-2023)
-
Table China Acromegaly and Gigantism Drugs Production Value by Region (2018-2023)
-
Table China Acromegaly and Gigantism Drugs Production Value Share by Region (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Production Value Share by Region (2018-2023)
-
Table China Acromegaly and Gigantism Drugs Sales Volume by Region (2018-2023)
-
Table China Acromegaly and Gigantism Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Sales Volume Share by Region (2018-2023)
-
Table China Acromegaly and Gigantism Drugs Sales Value by Region (2018-2023)
-
Table China Acromegaly and Gigantism Drugs Sales Value Share by Region (2018-2023)
-
Figure China Acromegaly and Gigantism Drugs Sales Value Share by Region (2018-2023)
-
Table North China Acromegaly and Gigantism Drugs Production Volume by Type (2018-2023)
-
Table North China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Table North China Acromegaly and Gigantism Drugs Sales Volume by Application (2018-2023)
-
Table North China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Acromegaly and Gigantism Drugs Production Volume by Type (2018-2023)
-
Table Central China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Acromegaly and Gigantism Drugs Sales Volume by Application (2018-2023)
-
Table Central China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Acromegaly and Gigantism Drugs Production Volume by Type (2018-2023)
-
Table South China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Table South China Acromegaly and Gigantism Drugs Sales Volume by Application (2018-2023)
-
Table South China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Acromegaly and Gigantism Drugs Production Volume by Type (2018-2023)
-
Table East China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Table East China Acromegaly and Gigantism Drugs Sales Volume by Application (2018-2023)
-
Table East China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Acromegaly and Gigantism Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Acromegaly and Gigantism Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Acromegaly and Gigantism Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Acromegaly and Gigantism Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Acromegaly and Gigantism Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Acromegaly and Gigantism Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Acromegaly and Gigantism Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Acromegaly and Gigantism Drugs Sales Volume Share by Application (2018-2023)
-
Table Ipsen Company Profile
-
Table Ipsen Acromegaly and Gigantism Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Acromegaly and Gigantism Drugs Revenue, Price and Gross (2018-2023)
-
